These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2016248)

  • 41. [Treatment of adjustment disorder with anxiety: efficacy and tolerance of etifoxine in a double-blind controlled study].
    Servant D; Graziani PL; Moyse D; Parquet PJ
    Encephale; 1998; 24(6):569-74. PubMed ID: 9949940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A clinical trial of buspirone and diazepam in the treatment of generalized anxiety disorder.
    Ross CA; Matas M
    Can J Psychiatry; 1987 Jun; 32(5):351-5. PubMed ID: 3308052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Buspirone, a novel nonbenzodiazepine anxiolytic.
    Kastenholz KV; Crismon ML
    Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Buspirone: sedative or stimulant effect?
    Manfredi RL; Kales A; Vgontzas AN; Bixler EO; Isaac MA; Falcone CM
    Am J Psychiatry; 1991 Sep; 148(9):1213-7. PubMed ID: 1883000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risperidone for controlling aggressive behavior in a mentally retarded child: a case report.
    Maneeton N; Intaprasert S; Srisurapanont M
    J Med Assoc Thai; 2001 Jun; 84(6):893-6. PubMed ID: 11556472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Buspirone for the Treatment of Generalized Anxiety Disorder in Williams Syndrome: A Case Series.
    Thom RP; Keary CJ; Waxler JL; Pober BR; McDougle CJ
    J Autism Dev Disord; 2020 Feb; 50(2):676-682. PubMed ID: 31724120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Buspirone: Back to the Future.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2015 Nov; 53(11):21-4. PubMed ID: 26535760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Movement disorders and new azapirone anxiolytic drugs.
    Jann MW; Froemming JH; Borison RL
    J Am Board Fam Pract; 1990; 3(2):111-9. PubMed ID: 2185606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Buspirone in the treatment of posttraumatic stress disorder.
    Wells BG; Chu CC; Johnson R; Nasdahl C; Ayubi MA; Sewell E; Statham P
    Pharmacotherapy; 1991; 11(4):340-3. PubMed ID: 1923917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can buspirone induce rebound, dependence or abuse?
    Lader M
    Br J Psychiatry Suppl; 1991 Sep; (12):45-51. PubMed ID: 1840763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Buspirone: an anxioselective alternative for the management of anxiety disorders.
    Riblet LA; Eison AS; Eison MS; Newton RE; Taylor DP; Temple DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):663-8. PubMed ID: 6364236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals.
    McRae AL; Sonne SC; Brady KT; Durkalski V; Palesch Y
    Am J Addict; 2004; 13(1):53-63. PubMed ID: 14766438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Benzodiazepine behavioral side effects: review and implications for individuals with mental retardation.
    Kalachnik JE; Hanzel TE; Sevenich R; Harder SR
    Am J Ment Retard; 2002 Sep; 107(5):376-410. PubMed ID: 12186578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The pharmacological management of aggressive and autoaggressive behaviour in mentally retarded patients with melperone (author's transl)].
    Hacke W
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Jan; 13(1):20-4. PubMed ID: 6102772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beta adrenergic blocking medications for aggressive or self-injurious mentally retarded persons.
    Ruedrich SL; Grush L; Wilson J
    Am J Ment Retard; 1990 Jul; 95(1):110-9. PubMed ID: 1974768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone).
    Tollefson GD; Montague-Clouse J; Tollefson SL
    J Clin Psychopharmacol; 1992 Feb; 12(1):19-26. PubMed ID: 1552035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of generalised anxiety disorder with a short course of psychological therapy, combined with buspirone or placebo.
    Bond AJ; Wingrove J; Valerie Curran H; Lader MH
    J Affect Disord; 2002 Dec; 72(3):267-71. PubMed ID: 12450644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The assessment and treatment of performance anxiety in musicians.
    Clark DB; Agras WS
    Am J Psychiatry; 1991 May; 148(5):598-605. PubMed ID: 2018160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modern treatment modalities in anxiety.
    Goldberg HL
    S Afr Med J; 1989 Jun; 75(12):xxxii-iii. PubMed ID: 2727851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Influence of Orgametril-induced amenorrhea on the emotional condition and aggressivity in women and girls with mental retardation].
    Röding G
    Med Monatsschr; 1976 Sep; 30(9):415-21. PubMed ID: 979905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.